Today's Small Cap Stocks Pulse
Deep Fission targets up to $1.66B valuation in fresh Nasdaq IPO
Deep Fission announced a Nasdaq IPO seeking $157M at $24‑$26 per share, which would value the company at as much as $1.66B. The filing shows its cash deficit widened to $88.1M in March from $56.2M in December.
Elite Express Holding Inc. Reports First Quarter 2026 Results
Elite Express Holding Inc. posted first‑quarter 2026 revenue of $805,298, a 16.3% year‑over‑year increase, while narrowing its net loss to $110,104, a 46.3% improvement. Gross profit turned positive at $157,365, lifting the gross margin to 19.4% from a 4.7% loss a year earlier. Operating expenses rose sharply to $464,606, driven by costs associated with its recent Nasdaq listing. Interest income from its loan portfolio added $199,830, partially offsetting higher expenses.
Jewett-Cameron Reports Fiscal 2026 Second Quarter Operational and Financial Results
Jewett‑Cameron Trading Co. reported fiscal 2026 Q2 results, showing revenue of $10.5 million, a 16% increase year‑over‑year. Gross profit margin fell to 15.7% as the company sold excess cedar fencing and pet inventory at low margins while facing higher raw‑material, shipping...
New SPACs: Irenic Acquisition Corp. (IACQU), Alpex Acquisition Corporation File for IPOs
Irenic Acquisition Corp. (ticker IACQU) and Alpex Acquisition Corp. have each filed Form S‑1 to launch new special purpose acquisition companies (SPACs). Irenic aims to raise roughly $200 million to pursue targets in technology and clean‑energy sectors, while Alpex seeks a...
Arxis (ARXS) IPO Deck
Arxis (ticker ARXS) has filed an initial public offering, presenting a deck that outlines its business of designing and manufacturing mission‑critical electronic and mechanical components for aerospace, defense, and specialized industrial customers. The company highlights its role supplying parts for...
Alamar Biosciences (ALMR) IPO Deck
Alamar Biosciences (ticker ALMR) is positioning its commercial‑stage proteomics platform for an initial public offering, as detailed in an investor deck released on April 13, 2026. The company’s technology delivers ultra‑sensitive protein biomarker detection, enabling researchers to identify disease signatures at earlier stages...
Deal Undervalues Secure, Shareholders Lose Billions
If this deal goes through as written, it's an incredibly disappointing outcome for $SES.TO shareholders. Our base case was C$34/share using conservative assumptions. Instead, shareholders are being asked to sell a scarce, high-quality waste infrastructure asset for C$24.75/share, mostly in GFL...
Cloud Deployment Margins Rebound, Set to Rise Further
"The margin trajectory of cloud-based deployment segment is far more interesting. Notice how gross margin here was precipitously falling and even turned negative in 1H’25 when the Chinese labs were essentially on a death march to grab market share. However,...
X-Energy Files IPO for SMR Venture, Eyes $2.3 Trillion Market
X-Energy has submitted a draft registration statement to the SEC for an IPO under the ticker XE, positioning its Xe-100 small modular reactor technology to serve a projected $2.3 trillion market. Backed by Amazon, Dow and other investors, the company aims...
Foresight Reports 2026 First Quarter Results
Foresight Financial Group reported a net income of $3.89 million for Q1 2026, a 429% jump from the same quarter a year earlier and a 53% rise versus the prior quarter. Diluted earnings per share surged to $1.07, up from $0.20 in...
Russell 2000 (Top Weights) Earnings Estimates
Analysts tracked earnings estimates for the 30 most heavily weighted Russell 2000 small‑cap stocks, comparing data from February 12 2026 to April 13 2026. In the past 60 days, more forecasts moved higher than lower, yielding an 18:12 up‑to‑down ratio. Despite the bullish revision...
How This Biotech Stock Skirted Today's Selloff
Revolution Medicines (RVMD) surged 35.5% to $131.35, briefly touching a record $135.81 after reporting that its pancreatic‑cancer pill daraxonrasib cut death risk by 60% in a Phase 3 trial. Leerink and Guggenheim raised price targets to $147 and $174, respectively. The...
Fuel Station Operator Yesway Seeks $321 Million in US IPO
Yesway Inc., a Fort Worth‑based convenience store and fuel station chain, filed to raise up to $321 million by selling roughly 14 million shares at $20‑$23 each. At the top of the range the offering would value the company at about $1.4 billion....
The IPO Buzz: Obesity-Focused Kailera Therapeutics Sets $500 Million IPO
Kailera Therapeutics, an obesity‑focused biotech developing a weekly GLP‑1 injection and a daily oral pill, filed an S‑1/A to raise $500 million. The company will offer 33.33 million shares at $14‑$16 each, which would place its market value near $1.8 billion if priced...
Fundamental Analysis Predicts Double‑digit Gains Across Ten Stocks
Not a guess — based on fundamentals, trend, and valuation. • 🚀 ($OKLO) — 50 → 100 • 🚀 ($IONQ) — 29 → 68 • 🚀 ($CIFR) — 16 → 25 • 🚀 ($SOFI) — 16 → 25 • 🚀 ($SERV) — 8 → 19 •...
Physical AI and Space Infrastructure Outpace Software Names
ListingTrack Weekly Theme Recap (Week Ending 04/10/26) This week, Next Gen Defense and New Space both traded higher, with strength skewed toward space infrastructure, Earth observation and physical AI platforms, while pockets of software‑heavy cyber, AI decision‑support and one launch name...
The IPO Window Reopens for Small Caps
The U.S. IPO market rebounded in 2025 with 371 listings, a 40% jump from 2024, marking the third year of recovery. A pipeline of heavyweight private firms—including Anthropic, OpenAI, SpaceX and Canva—promises continued issuance into 2026. Small‑cap stocks are benefiting...
Hisamitsu Pharmaceutical Posts 12% Profit Drop Despite 4.5% Revenue Rise
Hisamitsu Pharmaceutical Co. announced full‑year earnings of ¥19.16 bn, a 12% fall from the prior year, even as revenue rose 4.5% to ¥163.0 bn. The mixed results underscore challenges in its biotech‑focused product lines amid a tightening Japanese market.
SCHA: Attractive Valuations Support Upside For U.S. Small Caps
The Schwab US Small‑Cap ETF (SCHA) has posted a solid start to 2026, buoyed by historically low valuations and a heavier weighting toward the energy‑exporting U.S. economy. While its valuation gap with large caps has narrowed, analysts expect the fund...
Prediction: Buying This Biotech Stock Today Could Set You Up for Life
Mirum Pharmaceuticals (NASDAQ:MIRM) has surged more than 120% over the past year, driven by strong sales of its rare‑disease therapies. In Q4 2025 the company posted a 50% jump in net product revenue, with Livmarli alone generating $360 million. Mirum expects four...
Canada Nickel Company: Navigating the Lassonde Trough Towards Construction
Canada Nickel Company (CNC) remains in the “Lassonde trough,” the gap between feasibility studies and construction for its Crawford nickel project. The company faces a CAD 29.7 million (≈US $21.7 million) bridge loan maturing in May 2026, offset by about CAD 13.8 million (≈US $10 million) in cash. Visibility...
Dynagas LNG: Mispricing Risk, Undervaluing Cash Flow
Dynagas LNG Partners (DLNG) is trading at distressed levels because of its exposure to Russian sanctions and an aging LNG carrier fleet, yet its cash flow remains strong. The company has been actively deleveraging, redeeming $55 million of preferred stock and...
Cordel Secures District Line LiDAR Deal Amid Rail Digitisation Surge
Macro: urban rail digitisation accelerates; Cordel wins District Line LiDAR+AI rollout after Central Line success; key: TfL adoption and in‑tunnel geo‑location; risk: execution; trading insight: initiate a small long in CRDL on pullbacks. — Viktor Kopylov, PhD, CFA More insights: t.me/si14Kopylov
Resources Top 5: Gas Drills, Tungsten Targets and Approvals Lift Small Caps
The latest Resources Top 5 roundup highlights three small‑cap catalysts. Invictus Energy secured a renewed environmental impact assessment in Zimbabwe, clearing the path for high‑impact gas drilling at Cabora Bassa. Viking Mines listed on the US OTC market, expanding access for North‑American...
Small-Cap Stock Enviro Infra Surges 15% Despite Weak Stock Market Sentiment After This Business Update
Enviro Infra Engineers’ shares surged nearly 15% on the BSE, climbing from ₹173.35 to an intraday high of ₹199.15, even as the broader Sensex fell more than 2%. The rally followed the company’s filing that it received Letter of Empanelment...
WISE Posts Strong Results, Nasdaq Listing May 11
Very strong results by $WISE in my view. Expected listing on the Nasdaq is already on May 11! (less than a month)
Mon 13 Apr 2026 - Paul Scott's Small/Mid Cap Value Report
Paul Scott released his weekly Small/Mid Cap Value Report on April 13, 2026, highlighting a curated list of fifteen small‑ and mid‑cap equities he believes are undervalued. The report emphasizes low price‑to‑earnings multiples, strong dividend yields, and projected earnings beats...
Xref Reports Strong Q3 FY26 as ARR Surges 54% and EBITDA Turns Positive
Xref reported a dramatic turnaround in FY26 Q3, with annual recurring revenue climbing to $10.6 m, a 54% year‑on‑year increase. The new hire‑to‑retire platform now accounts for 97% of sales, up from 66% in the prior period. Cost discipline drove operational...
EML Payments Slashes FY26 EBITDA Guidance by 20% on Implementation Delays and Weak Trading
EML Payments trimmed its FY26 underlying EBITDA outlook by roughly 20%, now forecasting $31‑33 million USD (previously $38‑40 million USD). The downgrade stems from delayed program go‑lives and weaker‑than‑expected trading in its northern‑hemisphere operations. Despite the revenue shortfall, the company says operating...
Neila Creek Site Visit Takeaways and What’s Ahead for Golden Globe's Gold Projects
Golden Globe Resources (ASX:GGR) is advancing its Neila Creek project in New South Wales, having completed two diamond drill holes and started a third. Samples from the first two holes are now in the assay lab, with results expected soon....
Queen Alexandra Infill Hits Boost Redcastle’s Gold Development Plans
Redcastle Resources’ infill drilling at the Queen Alexandra (QA) gold project in Western Australia returned high‑grade assays, including 4 m at 12.3 g/t Au from 32 m depth, confirming that mineralisation extends below and beyond the 2025 conceptual pit. The results broaden the...
QD Laser Inc. (6613): Peak Market Cap ¥64.6B, Revenue ¥1.3B, 49 Employees. What It Takes for These Numbers to Make...
QD Laser Inc., a veteran quantum‑dot laser producer, saw its market capitalization surge to roughly ¥64.6 billion (about $430 million) in March 2026 before retreating amid extreme volatility. Despite the lofty valuation, the firm generated only ¥1.3 billion ($8.7 million) in annual revenue and...
ALAB Jumps 15% on Day 73 Research
$ALAB just surged 15% I covered this at Day 73 of my research series Get alerted for FREE when DVR stocks move like this next time → link in bio
FMKT Gains 1.8% as Deregulation ETF Leads
Today's close: The Free Markets ETF ( $FMKT ) at $21.27, climbing 1.79% since yesterday. Looking for opportunity in regulatory change? $FMKT is the pioneer ETF exclusively investing in companies we believe are positioned to benefit from deregulation. https://t.co/oO1zGkqC4s
Amneal Projects $3.1B 2026 Revenue, Leverages Pfizer GLP‑1 Manufacturing Deal
Amneal Pharmaceuticals guided 2026 revenue to $3.05‑$3.10 billion and highlighted a manufacturing partnership with Pfizer’s Metsera unit for GLP‑1 therapies. The plan leans on a diversified portfolio, accelerated affordable‑medicine launches, and a shift toward higher‑value injectables, while specialty sales face flat...
Factor Goes Long on Small‑Cap ETFs, Targets Higher Gains
The children have entered the parade. The Factor company account is long in this space. Much higher targets in mind. $SCHA $IWM Stay tuned. Follow the parade here: https://t.co/gDeM5nTRIY https://t.co/6CxE0wC8OT
OKLO Surges Above 10/21 MA, Short Float Highlights
$OKLO back over 10/21 ma and the gap up from last week test and bounce. Note the short float. https://t.co/shm0yFO6wS
Lexaria Bioscience Corp (LEXX) Q2 2026 Earnings Call Transcript
Lexaria Bioscience Corp (LEXX) reported a Q2 2026 net loss of $178.9 million, primarily from $164.5 million of unrealized Solana losses as the token fell 40% during the quarter. Revenue rose to $8.1 million, more than doubling year‑over‑year, driven by its newly launched digital‑asset...
FGFH's 9% ROE Boosts Stock, Yet Remains Undervalued
Today’s state of community bank stocks. $FGFH printed a 9% ROE quarter today. The stock is up 44% in the last year and still trades below book value. Perhaps justified as the improved results still don’t earn independence. https://t.co/1Uj2Cz2dR2 https://t.co/EFXtj5yKpY
Off‑the‑Shelf CAR‑T Shows Promise Delaying Lymphoma Relapse
Allogene data suggest ‘off-the-shelf’ CAR-T could delay relapse in lymphoma https://t.co/UrSNYpQFqB by @gwendolynawu $ALLO + 25%
Biomerica Inc (BMRA) Q3 2026 Earnings Call Transcript
Kestra Medical Technologies reported Q3 2026 revenue of $24.6 million, a 63% year‑over‑year increase driven by a 58% rise in Assure system prescriptions. Gross margin expanded to 52.6%, marking the ninth consecutive quarter of margin growth and supporting a path toward...
Nevada Sunrise Metals Sees Massive Volume Surge, Hints Reversal
Nevada Sunrise Metals $NEV.V $NVSGF Friday saw the 3rd Largest volume day in over 2 years as price closed off its lows. Reversal? Their Griffon Gold project produced 62K oz Gold in 1998-99 with Gold under $300/oz! ...
GUNR Stalls at $56 Resistance, Indicators Weakening
GUNR is looking tired here. Finding resistance at $56, moving averages starting to flatten and RSI trending in the opposite direction https://t.co/2tyAABjBC1
Envirotech Vehicles Inc (EVTV) Q4 2025 Earnings Call Transcript
EVgo reported a strong fourth quarter and full‑year 2025, delivering $384 million in revenue, a 50% year‑over‑year increase, and achieving adjusted EBITDA breakeven for the first time with $12 million for the year. The company expanded its network to 5,100 stalls, boosting...
Momentum Turnarounds Hit Targets, Stops Trail Higher
Hitting some targets today in a few of those hold-your-nose, turnaround momentum names from late last week. Stops are now trailing higher, CoreWeave in this example $CRWV https://t.co/tgj1PbmcSG
LEG Sale Undervalued
Super disappointed in $LEG sale outcome... shares are worth more than the $11-12 outcome... plus, LEG is inning #1 of capital allocation inflection https://t.co/VflyivPAAE
Gold Production Rises, Cash Surges, Guidance Stays Steady
Minera Alamos $MAI.V $MAIFF Q1 2026: Produced 8,734 oz gold at Pan mine Sold 9,134 oz Cash up to $46M (from $34M YE2025) ~18k oz cumulative since Oct 2025 acquisition. 2026 guidance unchanged: 32-38k oz.
Spyre's SPY001 Achieves 40% Remission in UC Trial
Spyre $SYRE just reported SPY001 (long-acting alpha4beta7 antibody) ulcerative colitis induction data. Here's the efficacy chart, notable for a 40% clinical remission rate at week 12, albeit with small number of patients. https://t.co/aEoLWPRjEL
ALLO's Alpha-3 DLBCL Data Set to Spark Pre‑Market Move
Key $ALLO catalyst coming pre market today, with first data from cema-cel's Alpha-3 study in DLBCL consolidation. What to look for: https://t.co/a19BVEppqP
Undiscovered Miner Gem Sparks Unexpected Excitement
WTF do I know about miners BUT this still looks like an undiscovered gem. #ORR https://t.co/gD8WEwQlC3
CHH Shows Strong Results, Yet Key Line Misphrased
#CHH results as robust as their crockery…but one line stood out as both critical to the investment case…and mysteriously badly worded https://t.co/BtL3NbzipO